SOAT1 and in situ carcinoma: Relevant evidence indicates that TNF may activate NF-κB (83) or indirectly activate STAT proteins through secondary cytokines (such as IL-6) (84), thereby inducing CIS expression and forming a negative feedback inhibition of the JAK-STAT pathway (69).